Sign up Trump’s returnA newsletter featuring the second President Trump’s application.
Donald Trump declared that a person who could always promote his tricks for trading struck one of his best transactions on Tuesday. Trump said, “This is one of the largest medical announcements made by this office,” he said at the elliptical office next to him. They gathered to announce that the administration had cut a contract with the pharmaceutical giant Huiza. I was surprised to see it.
Even the drug industry lobbyist Reported By what Pfizer agrees. The company has surpassed Trump’s attempt to reduce pharmaceutical costs, but promised to reduce US drug costs. A low price is chargedS Other developed countries. Pfizer agreed to participate in Trumprx, a new website announced on Tuesday, and agreed that Americans will be able to buy certain drugs with a steep discount.
Since entering politics ten years ago, Trump has been obsessed with believing that pharmaceutical companies are chasing Americans by raising the price of less -selling drugs in other developed countries. Trump declared that pharmaceuticals are “avoiding murder,” at their first press conference as the next presidential president in 2017. At the end of Trump’s first month, he summoned his pharmaceutical management to the White House to need a needle for the problem. “I think you know well. It’s very unfair in this country,” he said. He sent a lot of first terms of term disclosure after the policy to reduce the amount of Americans paid for prescription drugs. Over and again, Trump’s attempts have failed so far. Trump caught a white whale by allowing one of the world’s most powerful pharmaceutical companies to agree with his demands.
The president has a reason to get angry about the price of pharmaceuticals. According to the government report, in 2022, pharmaceutical companies have claimed residents of similar countries for almost three times more drugs for drugs. A significant percentage of Americans struggles to pay for prescriptions and sometimes Tragic. But Tuesday’s victory was a symbolic victory for the time being. It is not yet clear how much relief can be received by the patient at the pharmacy counter. Pfizer agreed to launch all new drugs at the price of “parity with other major markets.” But for the existing pharmaceutical portfolio, the company agreed to bring the price of pharmaceuticals with other countries for people of Medicaid, a government -run insurance program for the poor. Pharmaceutical companies already offer significant discounts to Medicaid’s Americans, and those included in this program only pay a small co -payment for prescriptions.
There is also ambiguity of Americans to benefit from Trumprx. According to the report, it will be released next year. We will provide our own drugs to consumers. According to Pfizer’s spokesman, the specific details of the company transaction with the company are confidential. She says that the Pfizer’s ointment of eczema will be offered at 80 % discount on Trumprx. But American You still have to pay Rather than using insurance, use drugs in pockets. The patient may still have to fork hundreds or thousands of dollars for prescriptions. Rachel Sachs, a drug price expert at the University of Washington, said, “It is not clear at all which patient’s financial resources to do this work.
Nevertheless, this is the first time that Trump has successfully broked the deal to bring about drug prices and pharmaceutical prices in other countries. The pharmaceutical company has paid attention to minor concessions, insisting that the high price paid by Americans to assist a large amount of money to research and develop new drugs. Other countries, Stephen UBL, chairman of the industry lobby group, PHRMA, “We do not pay a fair stake.” Sayed Earlier this year. In Europe, the price is lowered by negotiating with the pharmaceuticals about the price paid by the country.
Previously, the drug industry’s greedy “America first” price has collapsed. (In the statement, Bourla said that Pfizer has made a deal with “certain and stability.” The most notable thing in the Pfizer announcement is not the money to save Americans, but the method of extracting the transaction by the administration. In May, the president signed an administrative order that ordered the administration to implement the “most preferred country” policy. In other words, the pharmaceutical company means that Americans should provide the same price paid by people in other developed countries. The letter to the drug company soon continued and demanded a concession on Tuesday on Tuesday. “We will deploy all the tools in the arsenal to protect the American family,” the administration granted the deadline of September 29.
Pharmaceuticals were there before. In 2020, the White House published a similar last entry. The pharmaceutical company went away to discuss his demands, as long as he refused to invite Trump instead of brewing. Pfizer’s bourla Sayed at that time. Pharmaceuticals eventually provided less offer proposals for their own drug prices, but negotiations did not go anywhere. The Trump administration often relied on rushing to “most preferred nation” policies through the difficult process of enacting regulations. The pharmaceutical company has successfully sued the policy of its policy. Trump lost his re -election in November and killed the policy effectively. (Biden Administration has enacted its own drug price policy so that the government can directly negotiate with the pharmaceutical company about the price of Medicare, an insurance program for the elderly.)
But in his second term, Trump proved that he was more skilled in finding out how to get his way. LAW company,,, News mediaand university For the first nine months, the office was given to the president’s various demands. Pfizer is no different. The president announced that on the day of September 29, pharmaceutical companies that did not make some products in the United States will face 100 % tariffs. The announcement was not explicitly frame for pharmaceuticals who did not agree with Trump’s request for the previous price, but the three -year exemption from tariffs was enough to ride the painter. Bourla admitted that tariffs were “the most powerful tools for motivation to action,” and on Tuesday, the company’s concessions were “clearly motivated.”
The fact that it is an angry that giving Trump’s victory is more likely to make the president’s transaction even more sweet. Trump has a complex relationship with the company. Pfizer was part of the operating WARP SPEED, the first Trump administration’s efforts to develop and manufacture Covid vaccines quickly. But after losing the White House in 2020, Trump accused Pfizer that hides great news that Cobid vaccine is effective for the virus until a few days after the election. Dosing). Since then he has tried to play two ways with Pfizer. “It is very important for pharmaceutical companies to justify the success of various cobid drugs.” Posted to truth socialism transmission. “I showed information from Pfizer and others, but the result doesn’t seem to show the results to the public. Why not ???” Pfizer’s CEO now kissed the ring and thanked the president for his “friendship” while appearing in the elliptical office.
The experience seems to have daring the president. He told reporters on Tuesday that all the best pharmaceuticals came to the White House next week and cut a similar deal. “We are dealing with all of them,” Trump said. “And if we don’t deal, we will tariff.” The condition of additional transactions will be exactly how big the drug price change is for Americans. In particular, it is difficult to argue about the drop in pharmaceutical prices if the cuts are applied to more than simple Medicaid. But major changes can affect worldwide. Companies can also increase prices in other countries to compensate for cuts.
Nevertheless, Pfizer trading has put pharmaceuticals in the deficit, unlike other things that are seen in the Trump era. The pharmaceutical industry was found to be Trump’s reasonable opponent, but the lobbyists have not yet known how to fight with the second more shameless president in their second term than the first. The rules of the game have been changed. Pfizer’s deal may have surprised Trump, but other companies can do it well.
